U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 94

1.
Interferon subverts an AHR-JUN axis to promote CXCL13+ T cells in lupus
Calvin Law, Vanessa Sue Wacleche, Ye Cao, Arundhati Pillai, John Sowerby, Brandon Hancock, Alice Horisberger, Sabrina Bracero, Viktoriya Skidanova, Zhihan Li, Ifeoluwakiisi Adejoorin, Eilish Dillon, Isaac J. Benque, Diana Pena Nunez, Daimon P. Simmons, Joshua Keegan, Lin Chen, Tina Baker, Phillip Z. Brohawn, Hussein Al-Mossawi, Ling-Yang Hao, Brian Jones, Navin Rao, Yujie Qu, Stephen E. Alves, Accelerating Medicines Partnership: RA/SLE Network, A. Helena Jonsson, Katharina S. Shaw, Ruth Ann Vleugels, Elena Massarotti, Karen H. Costenbader, Michael B. Brenner, James A. Lederer, Judd F. Hultquist, Jaehyuk Choi, Deepak A. Rao
Nature. Author manuscript; available in PMC 2025 Jan 10.
Published in final edited form as: Nature. 2024 Jul; 631(8022): 857–866. Published online 2024 Jul 10. doi: 10.1038/s41586-024-07627-2
Correction in:
Nature. 2024 Jul 26
PMCID:
PMC11628166
AbstractArticlePDF–7.7M
2.
CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer
Yichou Wei, Chao Lin, He Li, Zhiying Xu, Jieti Wang, Ruochen Li, Hao Liu, Heng Zhang, Hongyong He, Jiejie Xu
Cancer Immunol Immunother. 2018 Feb; 67(2): 261–269. Published online 2017 Oct 31. doi: 10.1007/s00262-017-2083-y
PMCID:
PMC11028286
AbstractArticlePDF–1.8M
3.
Transcriptome analysis reveals the clinical significance of CXCL13 in Pan-Gyn tumors
Yue Ding, Quan Zhou, Bo Ding, Yang Zhang, Yang Shen
J Cancer Res Clin Oncol. 2024; 150(3): 116. Published online 2024 Mar 9. doi: 10.1007/s00432-024-05619-3
PMCID:
PMC10923744
AbstractArticlePDF–1.6M
4.
Correlation of serum and local CXCL13 levels with disease severity in patients with non-traumatic osteonecrosis of femoral head
Yong-Heng Zhao, Wen-Xiu Zhu, Qing-He Ye, Peng Zhang, Biao-Fang Wei
J Orthop Surg Res. 2024; 19: 162. Published online 2024 Mar 1. doi: 10.1186/s13018-024-04645-8
PMCID:
PMC10908116
AbstractArticlePDF–2.2M
5.
CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia
Heba A. Ahmed, Asmaa Nafady, Eman H. Ahmed, Emad Eldin Nabil Hassan, Walaa Gamal Mohamed Soliman, Mahmoud I. Elbadry, Ahmed Ahmed Allam
Ann Hematol. 2024; 103(3): 781–792. Published online 2023 Nov 9. doi: 10.1007/s00277-023-05540-8
PMCID:
PMC10867040
AbstractArticlePDF–3.9M
6.
CXCL13 in Cerebrospinal Fluid: Clinical Value in a Large Cross-Sectional Study
Deborah Katharina Erhart, Veronika Klose, Tatjana Schäper, Hayrettin Tumani, Makbule Senel
Int J Mol Sci. 2024 Jan; 25(1): 425. Published online 2023 Dec 28. doi: 10.3390/ijms25010425
PMCID:
PMC10779058
AbstractArticlePDF–2.6M
7.
Peripheral helper-T-cell-derived CXCL13 is a crucial pathogenic factor in idiopathic multicentric Castleman disease
Takuya Harada, Yoshikane Kikushige, Toshihiro Miyamoto, Kazuko Uno, Hiroaki Niiro, Atsushi Kawakami, Tomohiro Koga, Koichi Akashi, Kazuyuki Yoshizaki
Nat Commun. 2023; 14: 6959. Published online 2023 Oct 31. doi: 10.1038/s41467-023-42718-0
PMCID:
PMC10618253
AbstractArticlePDF–2.4M
8.
Cancer-associated fibroblasts drive CXCL13 production in activated T cells via TGF-beta
Richard A. O’Connor, Begoña Roman Martinez, Lilian Koppensteiner, Layla Mathieson, Ahsan R. Akram
Front Immunol. 2023; 14: 1221532. Published online 2023 Jul 13. doi: 10.3389/fimmu.2023.1221532
PMCID:
PMC10373066
AbstractArticlePDF–1.9M
9.
Single-cell spatial landscape of immunotherapy response reveals mechanisms of CXCL13 enhanced antitumor immunity
Mark Sorin, Elham Karimi, Morteza Rezanejad, Miranda W Yu, Lysanne Desharnais, Sheri A C McDowell, Samuel Doré, Azadeh Arabzadeh, Valerie Breton, Benoit Fiset, Yuhong Wei, Roni Rayes, Michele Orain, Francois Coulombe, Venkata S K Manem, Andreanne Gagne, Daniela F Quail, Philippe Joubert, Jonathan D Spicer, Logan A Walsh
J Immunother Cancer. 2023; 11(2): e005545. Published online 2023 Feb 1. doi: 10.1136/jitc-2022-005545
PMCID:
PMC9896310
AbstractArticlePDF–5.3M
10.
Changes in the Expression and Functional Activities of C-X-C Motif Chemokine Ligand 13 (CXCL13) in Hyperplastic Prostate
Daoquan Liu, Mingzhou Li, Xun Fu, Shu Yang, Zhen Wang, Jianmin Liu, Yan Li, Yongying Zhou, Pengfei Ren, Yuhang Guo, Xinghuan Wang, Michael E. DiSanto, Ping Chen, Xinhua Zhang
Int J Mol Sci. 2023 Jan; 24(1): 56. Published online 2022 Dec 21. doi: 10.3390/ijms24010056
PMCID:
PMC9820459
AbstractArticlePDF–6.9M
11.
CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progression
Katia Beider, Valeria Voevoda-Dimenshtein, Ali Zoabi, Evgenia Rosenberg, Hila Magen, Olga Ostrovsky, Avichai Shimoni, Lola Weiss, Michal Abraham, Amnon Peled, Arnon Nagler
J Hematol Oncol. 2022; 15: 144. Published online 2022 Oct 10. doi: 10.1186/s13045-022-01366-5
PMCID:
PMC9549634
AbstractArticlePDF–8.4M
12.
CXCL13 is elevated in inflammatory bowel disease in mice and humans and is implicated in disease pathogenesis
Ting Liu, Yu Liu, Chen-xi Liu, Yong-mei Jiang
Front Immunol. 2022; 13: 997862. Published online 2022 Sep 12. doi: 10.3389/fimmu.2022.997862
PMCID:
PMC9510369
AbstractArticlePDF–4.0M
13.
Physical and functional interactome atlas of human receptor tyrosine kinases
Kari Salokas, Xiaonan Liu, Tiina Öhman, Iftekhar Chowdhury, Lisa Gawriyski, Salla Keskitalo, Markku Varjosalo
EMBO Rep. 2022 Jun; 23(6): e54041. Published online 2022 Apr 5. doi: 10.15252/embr.202154041
PMCID:
PMC9171411
AbstractArticlePDF–1.9M
14.
CXCL13 expressed on inflamed cerebral blood vessels recruit IL-21 producing TFH cells to damage neurons following stroke
Aditya Rayasam, Julie A. Kijak, Lee Kissel, Yun Hwa Choi, Taehee Kim, Martin Hsu, Dinesh Joshi, Collin J. Laaker, Peter Cismaru, Anders Lindstedt, Krisztian Kovacs, Raghu Vemuganti, Shing Yan Chiu, Thanthrige Thiunuwan Priyathilaka, Matyas Sandor, Zsuzsanna Fabry
J Neuroinflammation. 2022; 19: 125. Published online 2022 May 27. doi: 10.1186/s12974-022-02490-2
PMCID:
PMC9145182
AbstractArticlePDF–8.9M
15.
CXCL13 as a Novel Immune Checkpoint for Regulatory B Cells and Its Role in Tumor Metastasis
Jun Ren, Tianxia Lan, Ting Liu, Yu Liu, Bin Shao, Ke Men, Yu Ma, Xiao Liang, Yu-quan Wei, Min Luo, Xia-wei Wei
J Immunol. 2022 May 15; 208(10): 2425–2435. Published online 2022 May 15. doi: 10.4049/jimmunol.2100341
PMCID:
PMC9125199
AbstractArticlePDF–2.1M
16.
CXC chemokine ligand‐13 promotes metastasis via CXCR5‐dependent signaling pathway in non‐small cell lung cancer
Chia‐Chia Chao, Wei‐Fang Lee, Shih‐Wei Wang, Po‐Chun Chen, Ayaho Yamamoto, Tsung‐Ming Chang, Shun‐Long Weng, Ju‐Fang Liu
J Cell Mol Med. 2021 Oct; 25(19): 9128–9140. Published online 2021 Aug 24. doi: 10.1111/jcmm.16743
PMCID:
PMC8500967
AbstractArticlePDF–1.6M
17.
CXCL13/CXCR5 axis facilitates endothelial progenitor cell homing and angiogenesis during rheumatoid arthritis progression
Chun-Hao Tsai, Chao-Ju Chen, Chi-Li Gong, Shan-Chi Liu, Po-Chun Chen, Chien-Chung Huang, Sung-Lin Hu, Shih-Wei Wang, Chih-Hsin Tang
Cell Death Dis. 2021 Sep; 12(9): 846. Published online 2021 Sep 13. doi: 10.1038/s41419-021-04136-2
PMCID:
PMC8437941
AbstractArticlePDF–5.4M
18.
The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF
Christine Harrer, Ferdinand Otto, Georg Pilz, Elisabeth Haschke-Becher, Eugen Trinka, Wolfgang Hitzl, Peter Wipfler, Andrea Harrer
Fluids Barriers CNS. 2021; 18: 40. Published online 2021 Aug 26. doi: 10.1186/s12987-021-00272-1
PMCID:
PMC8390062
AbstractArticlePDF–836K
19.
Identification of CXCL13 as an Immune-Related Biomarker Associated with Tumorigenesis and Prognosis in Cutaneous Melanoma Patients
Zebing Si, Konghe Hu
Med Sci Monit. 2021; 27: e932052-1–e932052-12. Prepublished online 2021 Jul 2. Published online 2021 Jul 11. doi: 10.12659/MSM.932052
PMCID:
PMC8280950
AbstractArticlePDF–2.7M
20.
The significance of metalloproteinase 3 (MMP-3), chemokine CXC ligand 13 (CXCL-13) and complement component C5a in different stages of ANCA associated vasculitis
Aleksandra Rymarz, Magdalena Mosakowska, Stanisław Niemczyk
Sci Rep. 2021; 11: 5132. Published online 2021 Mar 4. doi: 10.1038/s41598-021-84662-3
PMCID:
PMC7933137
AbstractArticlePDF–904K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center